Last viewed: BLU


Prices are updated after-hours



nasdaq:BLU BELLUS Health Inc.

BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology

(0.0% 1d) (0.0% 1m) (103.0% 1y) (0.0% 2d) (0.0% 3d) (0.0% 7d) (688.59% volume)
Earnings Calendar: 2023-08-09
Market Cap: $ 1,869,211,386

http://www.bellushealth.com
Sec Filling | Patents | 40 employees


(CA) BELLUS Health, Inc. is a biopharmaceutical development company which engages in the research and development of novel therapeutics for the treatment of chronic cough and other hypersensitisation disorders. Its product, BLU-5937, is being developed for the treatment of chronic cough and chronic pruritus, or chronic itch. The company was founded on June 17, 1993 and is headquartered in Laval, Canada.

chronic cough   hypersensitisation   treatment  

add to watch list Paper trade email alert is off

Press-releases


European Healthcare Acquisition & Growth Company B.V convenes annual general meeting of shareholders and publishes shareholder circular relating to proposed business combination with Croma-Pharma GmbH – Marketscreener.com
Published: 2023-05-16 (Crawled : 22:00) - spacfeed.com
RJAC | $10.39 0.0% 0 twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 0.0% C: 0.0%
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.28% C: 0.14%

business acquisition meeting growth
S-4/A – biote Corp. (0001819253) (Filer)
Published: 2023-05-16 (Crawled : 22:00) - spacfeed.com
RJAC | $10.39 0.0% 0 twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 0.0% C: 0.0%
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.28% C: 0.14%


BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition – Marketscreener.com
Published: 2023-05-16 (Crawled : 22:00) - spacfeed.com
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.28% C: 0.14%

health acquisition meeting
Metals Acquisition Corp Announces $35 million of Additional PIPE Subscription Agreements Executed for a Total of $175 million – Marketscreener.com
Published: 2023-05-16 (Crawled : 22:00) - spacfeed.com
RJAC | $10.39 0.0% 0 twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 0.0% C: 0.0%
MTAL | $13.55 0.3% 0.0% 0 twitter stocktwits trandingview |
| | O: 0.75% H: 0.0% C: -0.46%
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.28% C: 0.14%

acquisition total
Metals Acquisition Corp Announces $35 million of Additional PIPE … – The Bakersfield Californian
Published: 2023-05-16 (Crawled : 22:00) - spacfeed.com
RJAC | $10.39 0.0% 0 twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 0.0% C: 0.0%
MTAL | $13.55 0.3% 0.0% 0 twitter stocktwits trandingview |
| | O: 0.75% H: 0.0% C: -0.46%
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.28% C: 0.14%

acquisition
FS Development Corp : SPAC Company Investigated by the Portnoy … – Benzinga
Published: 2023-05-16 (Crawled : 22:00) - spacfeed.com
RJAC | $10.39 0.0% 0 twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 0.0% C: 0.0%
MTAL | $13.55 0.3% 0.0% 0 twitter stocktwits trandingview |
| | O: 0.75% H: 0.0% C: -0.46%
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.28% C: 0.14%

spac
MOVES-Nomura hires two bankers for clean transport technology deals – Yahoo Finance
Published: 2023-05-16 (Crawled : 21:00) - spacfeed.com
RJAC | $10.39 0.0% 0 twitter stocktwits trandingview |
n/a
| | O: 0.0% H: 0.0% C: 0.0%
MTAL | $13.55 0.3% 0.0% 0 twitter stocktwits trandingview |
| | O: 0.75% H: 0.0% C: -0.46%
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: -0.07% H: 0.28% C: 0.14%

technology
GSK reaches agreement to acquire late-stage biopharmaceutical company BELLUS Health
Published: 2023-04-18 (Crawled : 20:00) - biospace.com/
GSK | $39.765 -1.82% 260K twitter stocktwits trandingview |
Health Technology
| | O: -0.64% H: 0.23% C: -1.0%
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: 98.48% H: 0.62% C: 0.21%

health acquire agreement
BELLUS Health Announces Positive Results from its Phase 1 Bioavailability Equivalence Study Evaluating Once-Daily Extended-Release Formulation of Camlipixant in Comparison to Twice-Daily Immediate Release Formulation
Published: 2023-04-05 (Crawled : 17:00) - biospace.com/
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| | O: 0.87% H: 0.72% C: -6.92%

health positive results study blu-5937 camlipixant
BELLUS Health Reports Year 2022 Financial Results and Business Highlights
Published: 2023-03-21 (Crawled : 23:00) - biospace.com/
BLU | $14.74 0.03% 0 twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

business health year financial results
See all


Last 15 days Sec forms
File Id Form Published Date Transaction Date Direction Code Amount Transacted Owned Amount


Your Today's Watch List
Sign in to create a watchlist
Gainers vs Losers
34% 66%

Top 10 Gainers
BRTX | $1.475 11.74% 6.5M twitter stocktwits trandingview |
Professional, Scientific, and T...

CBAT | $1.01 9.78% 160K twitter stocktwits trandingview |
Producer Manufacturing

FANH | $4.06 9.73% 8K twitter stocktwits trandingview |
Finance

BCAN | $0.8378 8.81% 1.1M twitter stocktwits trandingview |
Construction

GFAI | $2.91 8.18% 38K twitter stocktwits trandingview |

HUMA | $3.07 6.97% 360K twitter stocktwits trandingview |
Manufacturing

ERIC | $5.09 6.26% 8.6M twitter stocktwits trandingview |
Electronic Technology

ENVX | $7.105 6.05% 760K twitter stocktwits trandingview |

BACK | $3.54 5.67% 8.2K twitter stocktwits trandingview |
Health Care and Social Assistan...

DZSI | $1.24 5.09% 4.7K twitter stocktwits trandingview |
Electronic Technology


Last 48 Hours Insiders Buying
RMCF | $3.6492 2.51% -7.2% 0 twitter stocktwits trandingview |
Consumer Non-Durables
| 20:10

12 months watchlist earnings calendar